Viewing Study NCT05447494


Ignite Creation Date: 2025-12-25 @ 1:39 AM
Ignite Modification Date: 2025-12-25 @ 11:55 PM
Study NCT ID: NCT05447494
Status: UNKNOWN
Last Update Posted: 2022-07-27
First Post: 2022-07-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 1/2 Study of CAN103 in Subjects With Gaucher Disease
Sponsor: CANbridge (Suzhou) Bio-pharma Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module